Монголын Анагаахын Сэтгүүлүүдийн Холбоо (МАСХ)
Mongolian Journal of Health Sciences, 2006, 1(3)
TRANS-ARTERIAL EMBOLIZATION OF HEPATOCELLULAR CARCINOMA WITH LIVER CIRRHOSIS
( Судалгааны өгүүлэл )

Z.Lkhagvasuren1 . Ts.Badamsed2, D.Gonchigsuren3

1Shastin Memorial Clinical Hospital
2Medical Research Institute
3Health Sciences University of Mongolia
 
Абстракт
In our study we included a total of 26 patients with splenomegaly caused bv cirrhosis and 401 patients with liver cancer and their diagnosis were confirmed by high lev els of serum alpha-fetoprotein (AFP) values, ultrasonography, computer tomography (CI) and angiographic findings. The Trans-Arterial Embolization (TAE) was done in 291 patients experiencing the last stage of cancer with cancer sizes of 3.0- 9.0 cm and in 43 inoperable patients with cancer si/es of 10.0-1 3.0 cm. Patients v\ith TAE had a median survival of 19.6 months while that of the control group was only 10.2 months (P<0.05). lor 74 patients treatment was effective and they lived up to 3-5 years. TAE is effective on prolonging survival of patients with L.iver Cancer and Cirrhosis. The combination ofsurgical treatment with transarterial embolization is effective method of treatment for the liver cancer located in the sixth segment of the right lobe and expands the lifespan for a long period. The embolization of spleen blood vessel is more effective for the B type of cirrhosis.
 


Зохиогчийн оруулсан түлхүүр үгс


Нийтлэлийн нээгдсэн тоо: 282
Судлаачдын бусад өгүүлэл
Зохиогчийн эрх хуулиар хамгаалагдсан. Дэлхийн Эрүүл Мэндийн Байгууллага, ©  2012.
Вебийг бүтээсэн Слайд ХХК